ph: 09 535 7218
FILTERED BY TAG:

Rivaroxaban

X

Rivaroxaban funding

September 17, 2018

Rivaroxaban not indicated or funded before POAC DVT scan

In line with the Auckland Regional HealthPathway, when there is a delay in obtaining community ultrasound for DVT, Enoxaparin continues to be the medication to be administered and funded through POAC. The issue of using rivaroxaban instead of enoxaparin for anticoagulation c...
Read more and comment
 

This product has been added to your cart

CHECKOUT